Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,941 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.
Qiu MZ, Bai Y, Wang J, Gu K, Yang M, He Y, Yi C, Jin Y, Liu B, Wang F, Chen YK, Dai W, Jiang Y, Huang C, Xu RH, Luo HY. Qiu MZ, et al. Among authors: yi c. Signal Transduct Target Ther. 2024 Dec 16;9(1):349. doi: 10.1038/s41392-024-02063-0. Signal Transduct Target Ther. 2024. PMID: 39676137 Free PMC article. Clinical Trial.
Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial.
Cheng K, Li X, Lv W, Zhao G, Zhou R, Chang C, Yang H, Li R, Li Z, Chen Y, Yi C, Yan O, Xiao C, Zhang Y, Xiong J, Huang Z, Shao W, You X, Guo W, He D, Ling W, Wang R, Tian B, Zhao C, Cao D. Cheng K, et al. Among authors: yi c. Signal Transduct Target Ther. 2024 Nov 25;9(1):321. doi: 10.1038/s41392-024-02031-8. Signal Transduct Target Ther. 2024. PMID: 39582060 Free PMC article. Clinical Trial.
Gemcitabine plus S-1 for metastatic pancreatic cancer.
Zhu H, Yi C, Zhao Y, Gou H. Zhu H, et al. Among authors: yi c. Medicine (Baltimore). 2018 Oct;97(41):e12836. doi: 10.1097/MD.0000000000012836. Medicine (Baltimore). 2018. PMID: 30313120 Free PMC article.
S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial.
Chen Y, Wu J, Cheng K, Li ZP, Luo DY, Qiu M, Gou HF, Yi C, Li Q, Wang X, Yang Y, Cao D, Shen YL, Bi F, Liu JY. Chen Y, et al. Among authors: yi c. Oncologist. 2019 May;24(5):591-e165. doi: 10.1634/theoncologist.2018-0901. Epub 2019 Jan 16. Oncologist. 2019. PMID: 30651398 Free PMC article. Clinical Trial.
Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen).
Wang X, Wang Y, Qiu M, Li Q, Li ZP, He B, Xu F, Shen YL, Gou HF, Yang Y, Cao D, Yi C, Liu JY, Luo DY, Liao ZY, Bi F. Wang X, et al. Among authors: yi c. Med Oncol. 2011 Dec;28 Suppl 1:S274-9. doi: 10.1007/s12032-010-9741-7. Epub 2010 Nov 30. Med Oncol. 2011. PMID: 21116880 Clinical Trial.
2,941 results